Medical Condition News

RSS

New Rush clinic brings trained clinicians to care for patients with pulmonary hypertension

Cardiologists and pulmonologists at Rush University Medical Center have teamed up to provide a new and better approach to treating patients with pulmonary hypertension, a disease affecting the heart and lungs. The new Rush Pulmonary Hypertension Clinic brings together a multidisciplinary team of clinicians with specialized training to care for patients with this very complex disease.

16 Feb 2011

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?

16 Feb 2011

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Halozyme Therapeutics, Inc. and Roche today announced the first patient received subcutaneous MabThera (rituximab), an anticancer biologic, in a Phase 3 registration trial using Enhanze technology.

16 Feb 2011

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.

16 Feb 2011

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress-a culprit in driving tumor growth.

16 Feb 2011

Study finds worse outcomes in workers undergoing spinal fusion surgery

For workers' compensation patients with chronic low back pain, spinal fusion surgery leads to worse long-term outcomes—including a lower rate of return to work—compared to nonsurgical treatment, suggests a study in the February 15th issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Feb 2011

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

More than 2.6 million Americans suffer from atrial fibrillation —an erratic heartbeat. If left untreated, the condition can lead to stroke or heart failure. For three decades, 58 year old David Ryan was one of the millions of Americans suffering from the disease.

16 Feb 2011

Research: Way heart responds to early beat is predictive of cardiac death

The way the heart responds to an early beat is predictive of cardiac death, especially for people with no conventional markers of cardiovascular disease, according to new research from Washington University School of Medicine in St. Louis.

16 Feb 2011

Diet high in Omega 3 oils benefits at risk Alzheimer's disease patients

Scientists today agree that there are five molecules that are known to affect or cause Alzheimer's disease, which plagues an estimated five million Americans. The potency of these molecules is linked to environmental factors such as diet and lifestyle.

16 Feb 2011

Aeolus receives BARDA contract for AEOL 10150 drug development against ARS

Aeolus Pharmaceuticals, a biopharmaceutical company developing a new class of broad spectrum catalytic antioxidant compounds that reduce oxidative stress, inflammation, and subsequent tissue damage-signaling cascades resulting from radiation exposure, today announced that the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services, has awarded Aeolus a contract for the advanced development of AEOL 10150 as a medical countermeasure against the pulmonary sub-syndrome of acute radiation syndrome.

16 Feb 2011

Endosense announces completion of enrollment in EFFICAS I clinical study

Endosense, a Swiss medical technology company focused on improving the efficacy, safety and accessibility of catheter ablation for the treatment of cardiac arrhythmias, has announced enrollment completion in the EFFICAS I clinical study.

16 Feb 2011

New study finds peer support greatly reduces symptoms of depression

Peer support offers promise as an effective, low-cost tool for fighting depression, a new study by the VA Ann Arbor Healthcare System and University of Michigan Health System finds.

16 Feb 2011

AML patient raises awareness in community about national stem cell registry

By the age of 28, Dana Severson was already an Iraq war veteran, an accomplished clinical engineer, a wife and mother. Days following her daughter Genevieve's first birthday, Severson was faced with a reality that would turn her life upside down. After several weeks of experiencing severe headaches and extreme exhaustion, the young mother was diagnosed with acute myeloid leukemia.

16 Feb 2011

CPIC scientists find rates of liver cancer in US-born Hispanic men increased by 87%

Thirty-year-old Pedro Espinosa's chances of developing liver cancer just skyrocketed. Born in the United States and of Hispanic descent, Pedro falls into a category of men in California whose liver cancer rates have nearly doubled over the past two decades, according to a recent study.

16 Feb 2011

Researchers identify cell of origin for sarcoma

Researchers at Oregon Health & Science University Doernbecher Children's Hospital have defined the cell of origin for a kind of cancer called sarcoma. In a study published today as the Featured Article in the journal Cancer Cell, they report that childhood and adult sarcomas are linked in their biology, mutations and the cells from which these tumors first start.

16 Feb 2011

Boston Scientific acquires novel technologies for treatment of peripheral chronic total occlusions

Boston Scientific Corporation today announced the acquisition of two novel technologies to treat peripheral chronic total occlusions (CTOs). These acquisitions add technology platforms that complement the Company's world-class portfolio of devices for lower extremity peripheral artery disease.

16 Feb 2011

Non-specialist mental health staff can treat depression with psychotherapy

Depression can be treated effectively with psychotherapy by mental health nurses with minimal training, according to new preliminary research findings.

16 Feb 2011

Covidien announces launch of TurboHawk Plaque Excision System for small vessels

Covidien, a leading global provider of healthcare products, today announced that it will launch the TurboHawk™ Plaque Excision System for small vessels next month in the United States and several international markets. The new system is intended to treat calcified and non-calcified lesion morphologies in small vessels, broadening minimally-invasive treatment options for Peripheral Arterial Disease (PAD).

16 Feb 2011

Study: Native Hawaiians face high risk of hemorrhagic stroke and diabetes at younger age

Native Hawaiians and Pacific Islanders may be at higher risk for hemorrhagic stroke at a younger age and more likely to have diabetes compared to other ethnicities, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

16 Feb 2011

ODA offers tips on how to handle winter-related dental injury

Family Day is a chance for parents and kids to enjoy the last few weeks of snowfall, which means tobogganing, skating and snowball fights. But any winter activity comes with a risk of injury to the teeth and mouth. The Ontario Dental Association wants to remind parents to take extra precautions during this holiday and learn what to do in case of a dental injury.

16 Feb 2011

Medical Condition News

New Rush clinic brings trained clinicians to care for patients with pulmonary hypertension

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Halozyme-Roche announce initiation of Phase 3 subcutaneous MabThera trial in follicular NHL

Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Study finds worse outcomes in workers undergoing spinal fusion surgery

BCVI offers multidisciplinary approach to treat patients with atrial fibrillation

Research: Way heart responds to early beat is predictive of cardiac death

Diet high in Omega 3 oils benefits at risk Alzheimer's disease patients

Aeolus receives BARDA contract for AEOL 10150 drug development against ARS

Endosense announces completion of enrollment in EFFICAS I clinical study

New study finds peer support greatly reduces symptoms of depression

AML patient raises awareness in community about national stem cell registry

CPIC scientists find rates of liver cancer in US-born Hispanic men increased by 87%

Researchers identify cell of origin for sarcoma

Boston Scientific acquires novel technologies for treatment of peripheral chronic total occlusions

Non-specialist mental health staff can treat depression with psychotherapy

Covidien announces launch of TurboHawk Plaque Excision System for small vessels

Study: Native Hawaiians face high risk of hemorrhagic stroke and diabetes at younger age

ODA offers tips on how to handle winter-related dental injury

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Exploring electron microscopy for plant and microbial imaging at the John Innes Centre

Latest News